Samuel Caughron, MD

Mawd Pathology Group

Latest Videos

Panel of four doctors discussing biomarker testing and safety in HER2-mutated non-small cell lung cancer during Ep. 4 of OncUpdates.

HER2 Testing and Treatment

07/29/2026

Ep. 4: Biomarker Testing and Safety Considerations in HER2-Mutated NSCLC

Charu Aggarwal, MD, MPHSamuel Caughron, MDPaolo Tarantino, MDRahul Gosain, MD, MBARohit Gosain, MD

Panel discussion on T-DXd in HER2-mutated and HER2-expressing cancers featuring Dr. Charu Aggarwal, Dr. Paolo Tarantino, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Samuel Caughron.

HER2 Testing and Treatment

07/25/2026

Ep. 3: Clinical Insights: The Evolving Role of T-DXd in HER2-Mutated and HER2-Expressing Cancers

Charu Aggarwal, MD, MPHSamuel Caughron, MDPaolo Tarantino, MDRahul Gosain, MD, MBARohit Gosain, MD

Panel of four doctors discussing HER2-positive NSCLC treatment options in a medical webinar.

HER2 Testing and Treatment

07/23/2026

Ep. 2: T-DXd Expands Treatment Opportunities for HER2-Positive NSCLC

Charu Aggarwal, MD, MPHSamuel Caughron, MDPaolo Tarantino, MDRahul Gosain, MD, MBARohit Gosain, MD

Panel of five doctors discussing HER2 testing in non-small cell lung cancer for OncUpdates.

HER2 Testing and Treatment

07/22/2026

Ep. 1: HER2 Testing Continues to Evolve in Non–Small Cell Lung Cancer

Charu Aggarwal, MD, MPHSamuel Caughron, MDPaolo Tarantino, MDRahul Gosain, MD, MBARohit Gosain, MD

Group of four doctors discussing HER2 testing and treatment options for lung cancer at a medical conference.

HER2 Testing and Treatment

07/16/2026

Multidisciplinary Team Discusses Diagnosing and Treating HER2–Positive NSCLC

Charu Aggarwal, MD, MPHSamuel Caughron, MDPaolo Tarantino, MDRahul Gosain, MD, MBARohit Gosain, MD